Semira Sheikh (University of Oxford)

Oncology biomarkers in clinical practice – a new horizon

4 May 2014 | By Heidi Olzscha (University of Oxford), Nicholas B. La Thangue (University of Oxford), Semira Sheikh (University of Oxford)

The ability to individualise a patient’s care has become a particularly pressing issue in the field of cancer therapeutics as there is a growing recognition that both the global incidence of cancer is steadily rising and the associated costs in terms of treatment and lost productivity are ever increasing. Advances…